Last updated on February 2018

The Efficacy and Safety of Dabigatran Etexilate for the Treatment of Cerebral Venous Thrombosis


Brief description of study

This is a single-center, prospective, randomized (1:1), open-label study with two parallel groups. This study is planned to investigate the efficacy and safety of dabigatran etexilate comparing with warfarin for the treatment of cerebral venous thrombosis.

Clinical Study Identifier: NCT03217448

Find a site near you

Start Over